XLONSPEC
Market cap58mUSD
Dec 27, Last price
46.00GBP
1D
0.00%
1Q
-9.80%
IPO
-76.41%
Name
Inspecs Group PLC
Chart & Performance
Profile
INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear and original equipment manufacturer products. It provides a range of branded and private label optical and sunglasses frames, as well as lens products. The company offers its eyewear under the Viktor & Rolf, Valerie, Ivana Helsinki, Lyle & Scott, Barbour, Day Birger, Liberty London, Henri Lloyd, Et Mikkelsen, Caterpillar, and BOTANIQ brand names. INSPECS Group plc sells its products directly to retailers, distributors, and brand partners, as well as through e-commerce channel. The company sells its products through a network of approximately 75,000 retail outlets in 80 countries worldwide. INSPECS Group plc was founded in 1988 and is headquartered in Bath, the United Kingdom.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
Income | ||||||||
Revenues | 203,292 -18.22% | 248,577 0.85% | 246,471 419.82% | |||||
Cost of revenue | 200,404 | 250,044 | 244,930 | |||||
Unusual Expense (Income) | ||||||||
NOPBT | 2,888 | (1,467) | 1,541 | |||||
NOPBT Margin | 1.42% | 0.63% | ||||||
Operating Taxes | 1,212 | (1,665) | (3,697) | |||||
Tax Rate | 41.97% | |||||||
NOPAT | 1,676 | 198 | 5,238 | |||||
Net income | (997) -87.24% | (7,816) 43.81% | (5,435) -39.02% | |||||
Dividends | (1,271) | |||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 355 | |||||||
BB yield | ||||||||
Debt | ||||||||
Debt current | 13,887 | 64,403 | 15,722 | |||||
Long-term debt | 66,085 | 44,207 | 91,585 | |||||
Deferred revenue | ||||||||
Other long-term liabilities | 652 | 1,634 | 8,505 | |||||
Net debt | 59,902 | 81,811 | 77,548 | |||||
Cash flow | ||||||||
Cash from operating activities | 12,665 | 5,077 | 20,017 | |||||
CAPEX | (5,750) | (4,235) | (7,645) | |||||
Cash from investing activities | (6,183) | (4,189) | (15,661) | |||||
Cash from financing activities | (8,835) | (4,398) | 1,704 | |||||
FCF | (20,553) | 2,148 | 1,239 | |||||
Balance | ||||||||
Cash | 20,070 | 26,799 | 29,759 | |||||
Long term investments | ||||||||
Excess cash | 9,905 | 14,370 | 17,435 | |||||
Stockholders' equity | 12 | 1,612 | 10,818 | |||||
Invested Capital | 166,278 | 212,798 | 225,047 | |||||
ROIC | 0.88% | 0.09% | 2.43% | |||||
ROCE | 1.70% | 0.60% | ||||||
EV | ||||||||
Common stock shares outstanding | 101,672 | 101,672 | 106,336 | |||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | 15,927 | 15,401 | 19,991 | |||||
EV/EBITDA | ||||||||
Interest | 4,017 | 2,855 | 2,298 | |||||
Interest/NOPBT | 139.09% | 149.12% |